Acebutolol and Pentoxifylline interaction
Acebutolol and Pentoxifylline: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Pentoxifylline label · effective 2026-05-15
Small decreases in blood pressure have been observed in some patients treated with pentoxifylline extended-release tablets; periodic systemic blood pressure monitoring is recommended for patients receiving concomitant antihypertensive therapy.
If indicated, dosage of the antihypertensive agents should be reduced.
Pentoxifylline extended-release tablets have been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, and antiarrhythmics, without observed problems.
From the Acebutolol (Acebutolol Hydrochloride) label · effective 2025-11-07
A bronchodilator, such as theophylline or a β2-stimulant, should be made available in advance with instructions concerning its use.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.